Dose equivalence and bronchoprotective effects of salmeterol and salbutamol in asthma

Thorax

Volumn 52, Issue 11, 1997, Pages 975-980

  Higham, Matthew A ^a   Sharara, Abdelmonen M ^a   Wilson, Peter ^a   Jenkins, Richard J ^b   Glendenning, G Alastair ^b   Ind, Philip W ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Dose equivalence; Salbutamol; Salmeterol

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; METHACHOLINE; PLACEBO; SALBUTAMOL; SALMETEROL;

ADULT; ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030831740     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.11.975     Document Type: Article

References (23)

1. Faurschou P. Chronic dose-ranging studies with salmeterol. Eur Respir Rev 1991;1:282-7.
2. Britton M. Salmeterol and salbutamol: large multicentre studies. Eur Respir Rev 1991;1:288-92.
3. Douglas NJ, Fitzpatrick MF. Effects of salmeterol on nocturnal asthma. Eur Respir Rev 1991;1:293-6.
4. Juniper EF, Johnston PR, Borkhoff CM, Guyatt GH, Boulet L-P, Haukioja A. Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol. Am J Respir Crit Care Med 1995;151:66-70.
5. 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax 1988;43:674-8.
6. Pearlman DS, Chervinsky P, LaForce C, Seltzer JM, Southern DL, Kemp JP, et al. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N Engl J Med 1992;327:1420-5.
7. Gongora HC, Wisniewski AFZ, Tattersfield AE. A single-dose comparison of inhaled albuterol and two formulations of salmeterol on airway reactivity in asthmatic subjects. Am Rev Respir Dis 1991;144:626-9.
8. Derom EY, Pauwels RA, Van Der Straeten MEF. The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours. J Allergy Clin Immunol 1992;89:811-5.
9. 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo. Br J Pharmacol 1991;104: 665-71.
10. 2-agonist. Am Rev Respir Dis 1989;139:A64.
11. Smyth ET, Pavord ID, Wong CS, Wisniewski AFZ, Williams J, Tattersfield AE. Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma. BMJ 1993;306:543-5.
12. Barrett TE, Strom BL. Inhaled beta-adrenergic receptor agonists in asthma: more harm than good? Am J Respir Crit Care Med 1995;151:574-7.
13. Boushey HA, Holtzman MJ, Sheller JR, Nadel JA. State of the art. Bronchial reactivity. Am Rev Respir Dis 1980;121: 389-413.
14. SEPCR Working Group on Bronchial Hyperreactivity. Guidelines for standardization of bronchial challenges with (nonspecific) bronchoconstricting agents. Bull Eur Physiopathol Respir 1983;19:495-514.
15. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-44.
16. Henderson JC, O'Connell F, Fuller RW. Decrease of histamine induced bronchoconstriction by caffeine in mild asthma. Thorax 1993;48:824-6.
17. American Thoracic Society. Standardization of spirometry 1987 update. Am Rev Respir Dis 1987;136:1285-98.
18. Dixon CMS, Ind PW. Inhaled sodium metabisulphite induced bronchoconstriction: inhibition by nedocromil sodium and sodium cromoglycate. Br J Clin Pharmacol 1990; 30:371-6.
19. Sterk PJ, Fabbri LM, Quanjer PH, Cockcroft DW, O'Byrne PM, Anderson SD, et al. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Respir J 1993;6(Suppl 16):53-83.
20. Johnson M, Butchers PR, Coleman RA, Nials AT, Strong P, Sumner MJ, et al. The pharmacology of salmeterol. Life Sci 1993;52:2131-43.
21. 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med 1992;327:1198-1203.
22. Ahrens RC, Bonham AC, Maxwell GA, Weinberger MM. A method for comparing the peak intensity and duration of action of aerosolized bronchodilators using bronchoprovocation with methacholine. Am Rev Respir Dis 1984; 129:903-6.
23. Rogers DF, Ganderton D. Determining equivalence of inhaled medications. Respir Med 1995;89:253-61.